IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Delphi Management Partners VIII, L.L.C.

Q3 2021 Holdings

Filed 2021-11-15 | 4 holdings | $138.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tandem Diabetes, Inc.(TNDM)Common Stock875372203$119.4K1,000,00086.2%
Karyopharm Therapeutics, Inc.(KPTIEUR)Common Stock48576U106$13.2K2,263,0069.5%
Calithera Biosciences, Inc.(CALAEUR)Common Stock13089P101$5.3K2,426,7023.8%
Mereo BioPharma Group PLC(MREO)ADS589492107$621256,7340.4%